NFE2L2 and cancer: Of note, some Nrf2 modulators are being currently evaluated in clinical trials for different disorders, such as cancer, neurodegenerative disorders and autoimmune diseases (Chartoumpekis et al., 2020; Panieri et al., 2020; Scuderi et al., 2020).